What is the most commonly used radionuclide in Nuclear Medicine?

What is the most commonly used radionuclide in Nuclear Medicine?

• A. Technetium-99m
• B. Iodine-131
• C. Gallium-67
• D. Fluorine-18

Answer: (A)

Technetium-99m is favored in Nuclear Medicine because it brings together imaging-quality gamma emission, a practical short half-life, and easy accessibility. Its 140 keV gamma rays are ideal for standard gamma cameras and SPECT, producing clear pictures with good detectability while keeping dose reasonable. The roughly 6-hour half-life is long enough to complete most studies but short enough to minimize radiation exposure, allowing multiple scans in a single patient visit if needed. A key practical advantage is its production from a molybdenum-99/technetium-99m generator, which means hospitals can routinely obtain Tc-99m without a local cyclotron. This, plus the ability to label Tc-99m with a wide range of compounds, makes it incredibly versatile for imaging many organs and conditions—bone scans, cardiac perfusion, liver and spleen function, brain imaging, and more. That combination of suitable physics, patient safety, and flexible radiopharmacy logistics is why Tc-99m dominates everyday nuclear medicine. In comparison, iodine-131, while used for thyroid studies and therapy, couples higher radiation dose and longer persistence with fewer broad imaging options. Gallium-67 has limitations in image quality and longer imaging times. Fluorine-18 is superb for PET and high-resolution imaging but requires PET infrastructure and different radiopharmacy workflows, making Tc-99m the most universally used radionuclide in conventional nuclear medicine.

Technetium-99m is favored in Nuclear Medicine because it brings together imaging-quality gamma emission, a practical short half-life, and easy accessibility. Its 140 keV gamma rays are ideal for standard gamma cameras and SPECT, producing clear pictures with good detectability while keeping dose reasonable. The roughly 6-hour half-life is long enough to complete most studies but short enough to minimize radiation exposure, allowing multiple scans in a single patient visit if needed.

A key practical advantage is its production from a molybdenum-99/technetium-99m generator, which means hospitals can routinely obtain Tc-99m without a local cyclotron. This, plus the ability to label Tc-99m with a wide range of compounds, makes it incredibly versatile for imaging many organs and conditions—bone scans, cardiac perfusion, liver and spleen function, brain imaging, and more. That combination of suitable physics, patient safety, and flexible radiopharmacy logistics is why Tc-99m dominates everyday nuclear medicine.

In comparison, iodine-131, while used for thyroid studies and therapy, couples higher radiation dose and longer persistence with fewer broad imaging options. Gallium-67 has limitations in image quality and longer imaging times. Fluorine-18 is superb for PET and high-resolution imaging but requires PET infrastructure and different radiopharmacy workflows, making Tc-99m the most universally used radionuclide in conventional nuclear medicine.